Edition:
India

Mitsubishi Tanabe Pharma Corp (4508.T)

4508.T on Tokyo Stock Exchange

1,177JPY
16 Jul 2019
Change (% chg)

¥-27 (-2.24%)
Prev Close
¥1,204
Open
¥1,200
Day's High
¥1,200
Day's Low
¥1,174
Volume
1,608,300
Avg. Vol
1,121,028
52-wk High
¥2,208
52-wk Low
¥1,174

Summary

Name Age Since Current Position

Masayuki Mitsuka

64 2015 Executive President, President, Representative Director

Megumi Ohtaki

Chief Compliance Officer, Executive Officer, Director of Pharmaceutical Affairs

Takashi Kobayashi

63 2018 Senior Managing Executive Officer, Representative Director

Yoshiaki Ishizaki

64 2018 Managing Executive Officer, Director

Seiichi Murakami

62 2018 Managing Executive Officer, Director

Eizo Tabaru

60 2017 Managing Executive Officer, Director

Takashi Tanaka

62 2018 Managing Executive Officer, Director

Yoshihiro Kobayashi

2019 Managing Executive Officer, Chief Director of Drug Fostering & Evolution

Eiji Tanaka

2019 Managing Executive Officer, President of Subsidiary

Hiroaki Ueno

2018 Managing Executive Officer

Yasutoshi Kawakami

Executive Officer, Chief Director of Sales

Yoshiharu Hayashi

Executive Officer, Chief Director of Drug Discovery, Director of Drug Discovery Project in Main Drug Discovery Unit

Mikio Himizu

2018 Executive Officer, Manager of Neuroderm

Kazutaka Kawashima

2017 Executive Officer, Director of Portfolio Management

Ryo Shimizu

Executive Officer, Director of Digital Transformation

Ryosuke Tanabe

Executive Officer, Chief Director of Supply Chain

Takeshi Matsumoto

62 2018 Director

Shigehiko Hattori

77 2011 Independent Director

Shigeki Iwane

65 2016 Independent Director

Tsutomu Kamijo

65 2017 Independent Director

Toshihide Doi

2017 Director of Accounting & Finance

Biographies

Name Description

Masayuki Mitsuka

Mr. Masayuki Mitsuka has been serving as Executive President, President and Representative Director in Mitsubishi Tanabe Pharma Corporation since October 2015. He is also serving as Director in The KAITEKI Institute, Inc. and its parent company, Mitsubishi Chemical Holdings Corporation. He used to work for three other companies, including ZOEGENE Corporation.

Megumi Ohtaki

Takashi Kobayashi

Mr. Takashi Kobayashi has been serving as Senior Managing Executive Officer and Representative Director in Mitsubishi Tanabe Pharma Corporation since April 2018. He joined the Company in April 1980. His previous titles include Managing Executive Officer, Chief Director of Research, Director of Business Administration and Chief Director of Drug Discovery in the Company.

Yoshiaki Ishizaki

Mr. Yoshiaki Ishizaki has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2018. His previous titles include Executive Officer Chief Director of Reliability Guarantee, Chief Compliance Officer and Director of Sales Promotion in Main Sales Unit in the Company. He used to work for another company.

Seiichi Murakami

Mr. Seiichi Murakami has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2018. He joined the Company in April 1980. His previous titles include Executive Officer, Director of 1st Medical Affairs, Chief Director of Sales, Chief Director of Development and Director of Development Planning in the Company.

Eizo Tabaru

Mr. Eizo Tabaru has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2017. He used to work for Mitsubishi Chemical Corporation and another company.

Takashi Tanaka

Mr. Takashi Tanaka has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2018. He joined the Company in April 1985. His previous titles include Executive Officer, Director of Pharmaceutical Planning, Director of Production Planning in Main Production Unit and Deputy Chief Director of CMC in the Company.

Yoshihiro Kobayashi

Eiji Tanaka

Hiroaki Ueno

Yasutoshi Kawakami

Yoshiharu Hayashi

Mikio Himizu

Kazutaka Kawashima

Ryo Shimizu

Ryosuke Tanabe

Takeshi Matsumoto

Mr. Takeshi Matsumoto has been serving as Director in Mitsubishi Tanabe Pharma Corporation since June 2018. He is also serving as Director in Life Science Institute, Inc., as well as Managing Executive Officer and Manager of Health & Care Strategy Office in Business Strategy Unit in a subsidiary, Mitsubishi Chemical Holdings.

Shigehiko Hattori

Mr. Shigehiko Hattori has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2011. He is also serving as Independent Director in Sapporo Holdings Limited, Brother Industries, Ltd. and Meiji Yasuda Life Insurance Company. He used to work for Shimadzu Corporation.

Shigeki Iwane

Mr. Shigeki Iwane has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2016. He is also serving as President and Representative Director in The Kansai Electric Power Company, Incorporated. He used to work for Kinden Corporation.

Tsutomu Kamijo

Mr. Tsutomu Kamijo has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2017. He is also serving as Chairman of the Board and Representative Director in Sapporo Holdings Limited.

Toshihide Doi